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Background: The Mini-BESTest is a clinical balance test that has shown a high sensitivity in detecting balance
impairments in elderly with Parkinson's disease (PD). However, its reproducibility between different raters and
between test occasions has yet to be investigated in a clinical context. Moreover, no one has investigated the
reproducibility of the Mini-BESTest's subcomponents (i.e. anticipatory postural adjustments; postural responses;
sensory orientation and dynamic gait).
We aimed to investigate the inter-rater and test-retest reproducibility (reliability as well as agreement) of the
Mini-BESTest, as well as its subcomponents, in elderly with mild to moderate PD, performed under conditions
assimilating clinical practice.
Method: This was an observational measurement study with a test-retest design.
Twenty-seven individuals with idiopathic PD (66 - 80 years, mean age: 73; Hoehn & Yahr: 2-3; 1-15 years since
diagnosis) were included. Two test administrators, having different experiences with the Mini-BESTest, administered the
test individually, in separate rooms in a hospital setting. For the test-retest assessment, all participants returned
7 days after the first test session to perform the Mini-BESTest under similar conditions. Intra-class correlation
coefficients (ICC2.1), standard error of measurement (SEMagreement), and smallest real difference (SRD) were analyzed.
Results: The Mini-BESTest showed good reliability for both inter-rater and test-retest reproducibility (ICC = 0.72 and
0.80). Regarding agreement, the measurement error (SRD) was found to be 4.1 points (accounting for 15% of the
maximal total score) for inter-rater reproducibility and 3.4 points (12% of the maximal total score) for test-retest
reproducibility. The investigation of the Mini-BESTest's subcomponents showed a similar pattern for both inter-rater
and test-retest reproducibility, where postural responses had the largest proportional measurement error, and sensory
orientation showed the highest agreement.
Conclusions: Our findings indicate that the Mini-BESTest is able to distinguish between individuals with mild to
moderate PD; however, when used in clinical balance assessments, the large measurement error needs to be
accounted for.
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Parkinson’s disease (PD), with a prevalence of more than
4 million people worldwide [1] and 22,000 in Sweden
[2], is the second most common neurodegenerative
disease. The incidence of PD, most common after the
age of 60 years [3], rises with age and is expected to
grow rapidly in the coming years [1]. As the disease
progresses, impaired balance control becomes one of the
main features, interfering with physical independence [4]
and quality of life [5,6]. Out of the four cardinal symp-
toms in PD (tremor, bradykinesia, rigidity and postural
instability), all but tremor are related to impaired balance
control [4,7]. Balance control in PD, being negatively
affected from the early stages of the disease, includes im-
pairments of postural responses as well as with turning
and gait, and is also related to an increased risk of falling
[4]. It is therefore vital for a balance test to identify the
array of problems that may occur in an individual with PD.
In order to help clinicians identify the specific balance
problems, the Balance Evaluation Systems Test (BESTest)
[8] was developed, addressing a variety of components
influencing balance control. However, being very com-
prehensive, it has been regarded as too time consuming.
Instead, this led to the development of the shortened,
more clinically applicable version; the Mini-BESTest
[9]. This test addresses subcomponents of balance con-
trol, such as anticipatory postural adjustments, postural
responses, sensory orientation and dynamic gait, and
has been found to be sensitive in disclosing balance im-
pairments among individuals with PD [10].
Reproducibility concerns the degree to which repeated
measurements in study objects provide similar results,
and can be divided into parameters of reliability or agree-
ment [11]. Whereas reliability measures aim to distinguish
study objects from each other despite measurement
errors, measures of agreement assesses the absolute meas-
urement error of a test (i.e., the exact measurement error
presented in the same units as the investigated item)
[11,12]. When investigating the reproducibility of a clinical
test, there are various aspects to take into consideration.
Sources of error for a test may depend upon the test
administrator, the tested subject, the instrumentation and/
or biological variability, as well as of the circumstances
under which the test takes place [11,13]. To gain fully
accountable information regarding the reliability of a test,
it is therefore important to take all possible sources of
error into account. However, the prevailing approach for
reproducibility investigations tend to be to use one person
to act as a test administrator, being responsible for test
instructions and the safety of the patient, and one or more
other persons that observe and rate the test performance
(by using the test instructions regarding how to grade
the test performance). Although such an observational
approach investigates the reproducibility of the test itself(by testing the actual grading scale), it lacks ecological
validity because such conditions do not assimilate clinical
practice. Indeed, the assessment of balance performance
in clinical practice is a rather complex situation, with the
clinician generally being responsible for giving the patients
clear and concise instructions, as well as for the adequate
interpretation (rating) of the test performance and the
safety of the patient. Such a situation is also dependent on
the relation between the clinician and the patient, that is,
whether or not the patient trusts the clinician enough to
perform challenging tasks adequately.
Previous studies have used the observational approach
of investigating inter-rater reproducibility of the Mini-
BESTest [8,14-18], whereas others have used video
recordings to rate the test retrospectively [19-21]. Such
approaches differ from clinical test situations, making
it difficult to generalize the results derived from these
studies to clinical practice. Moreover, at times different
physical therapists (with varied experience) may assess the
balance abilities of a single patient before and after a
rehabilitation period or at different stages in the health
care system. Therefore, it may be important also to
investigate the reproducibility of clinical tests that are
performed by clinicians with different experience.
Recent studies have found the Mini-BESTest to be
highly reproducible [14,15,18,22], but only one study
focused on individuals with PD exclusively [14]. In
addition, the majority of these studies have reported
their results only in form of the reliability parameter
intra-class correlation (ICC). From a clinical perspec-
tive, this may be problematic, as the ICC score is a relative
measure of reproducibility, thereby depending on the
variance between subjects (i.e., the ICC score will be
higher if there is much variability between subjects even
if the variability between tests is high, and vice versa)
[13,23]. Therefore, the ICC score preferably should be
complemented with measures of agreement (i.e., the exact
number of points that are likely to reflect the measure-
ment error), such as the standard error of measurement
(SEM) [12] and the smallest real difference (SRD) [24].
The SEM estimates an exact score that reflects the
within subject error variance, and can be presented
as SEMagreement (including systematic differences) or
SEMconsistency (excluding systematic differences) [11]. When
the SEM is known, the SRD (reflecting the exact measure-
ment error in a single individual) can be calculated [24].
Finally, as the reproducibility of the assessment may
vary between different areas of balance control, it might
also be of significance to investigate the reproducibility
of each of the Mini-BESTest’s subcomponents. Our aim
was therefore to investigate, in a clinical context, the
inter-rater and test-retest reproducibility of the Mini-
BESTest and its subcomponents in elderly with mild-to-
moderate PD.
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This study was designed as an observational measure-
ment study with a test-retest design.
The Regional Board of Ethics in Stockholm (Dnr:2009/
819-32, 2010/1472-32 and 2012/1829-32) provided their
ethical approval of the study.Participants
The participants were recruited from a balance interven-
tion study (BETA-PD trial [25]) and provided their written
informed consent to participate. However, none of the
participants took part in any kind of physical intervention
during the time of this study.
Inclusion criteria were a clinical diagnosis of “idio-
pathic” PD [26], Hoehn and Yahr stages 2 and 3, and ≥
60 years of age. Participants were excluded if they had a
diagnosis of other existing neurological disorders and/or
medical conditions affecting balance control.
Twenty-seven elderly (9 females; mean age 73; SD 4.1)
with mild to moderate PD (Hoehn & Yahr, stage 2, n = 16;
stage 3, n = 11) participated in this study; see Table 1.
All participants had a Mini Mental State Examination
(MMSE) [27] score of at least 24 points (indicating
adequate cognitive function to occur in this sample) and
were tested during the on-phase with regards to their
medication scheme. Twenty-four of the participants
reported self-perceived balance impairments, eight had
experienced at least one fall during the past 12 months,
12 were afraid of falling (answering “yes” or “no” to a
direct question), and one used a walking aid (cane).Outcome measures/assessment
The Mini-BESTest (also presented in Table 2) is a balance
test consisting of 14 items, including tasks divided into
four subcomponents: anticipatory postural adjustments,
postural responses, sensory orientation, and dynamic gait.
Items are scored from 0 (unable or requiring help) to 2
(normal) on an ordinal scale with the maximal total score
of 28 points. The items; single limb stance and compensa-
tory stepping correction (lateral), were assessed on both
the right and left sides. However, only the score of the
worst side was used to calculate the total score [9,28].Table 1 Participant demographics (n = 27)
Mean SD Range
Age (years) 73 4 66-80
Height (cm) 171 10 145-183
Weight (kg) 74 16 46-101
Body mass index (weight/length2) 25 3 18–31
Time since diagnosis (years) 6.2 4 1-15
UPDRS motor score 35 11 11-63
UPDRS = Unified Parkinson’s disease rating scale.Procedure
To investigate inter-rater reproducibility, two physical
therapists with different experiences of the Mini-BESTest
administered and rated the test performance on the same
day at Karolinska University Hospital, Stockholm. The
more-experienced rater (rater A) had administered and
rated the Mini-BESTest more than 100 times, whereas the
less-experienced rater (rater B) had administered the test
approximately ten times before this study started. To
synchronize their assessment of the Mini-BESTest, the
two raters met prior to the study on two occasions to dis-
cuss the principles of the test, and to practice its adminis-
tration and rating. However, during and after the test
sessions the raters were blinded to each other’s ratings.
Participants were briefly interviewed, using a standard-
ized protocol, regarding current health status including
years since diagnosis. Disease severity was measured with
the Unified Parkinson’s Disease Rating Scale (UPDRS)
[29], and cognitive function was assessed with the MMSE
[27]. Subsequently, the participants performed the Mini-
BESTest with each of the two test administrators, who
were situated in separate rooms. Randomization decided
which administrator to start with. The test procedure took
approximately one hour to complete.
For test-retest reproducibility, the more experienced
rater (rater A) reassessed the participants seven days later.
At the second test session, rater A performed a brief inter-
view, including questions regarding pain, medication,
activity, falls, and other possible incidents that might
have influenced their balance performance since the
previous session. Following this, the participants per-
formed the Mini-BESTest at the same location and time
of the day as they had performed the test the previous
week.
Data analysis
Statistical analyses were performed with SPSS (version
22, SPSS Inc., Chicago, IL). Cronbach’s alpha was used
to assess the internal consistency, where values of at
least 0.7 were considered acceptable [30]. Reliability was
investigated by means of ICC2.1 where one-way repeated
measures analysis of variance (ANOVA) were used to
calculate agreement between raters (inter-rater reprodu-
cibility) and test sessions (test-retest reproducibility),
regarding the total score of the Mini-BESTest as well as
its subcomponents. To categorize the level of ICC agree-
ment, we used Altman’s classification: < 0.20 = poor;
0.21–0.40 = fair, 0.41–0.60 =moderate, 0.61–0.80 = good,
0.81–1.0 = very good [31].
For parameters of agreement, first SEMagreement was
calculated as follows: SEM = √within subject error vari-
ance [32]. Following this, the SRD was calculated with a
95% Confidence Interval (CI), resulting in the following
formula: SRD = 1.96 × √2 × SEM [24]. Moreover, to
Table 2 Summary of the subcomponents and the items of the Mini-BESTest1
Anticipatory postural adjustments2 Sensory orientation2
- Sit to stand - Stance on firm surface; eyes open
- Rise to toes - Stance on foam surface; eyes closed
- Stand on one leg (right and left)4 - Stance on incline surface, eyes closed
Postural responses2 Dynamic gait3
- Compensatory stepping correction; forward - Change in gait speed
- Compensatory stepping correction; backward - Walk with head turns; horizontal
- Compensatory stepping correction; lateral (right and left)4 - Walk with pivot turns
- Step over obstacles
- Timed up & go with dual-task
1Maximal total score = 28 points, 2Maximal subcomponent score = 6 points, 3Maximal subcomponent score = 10 points, 4Only the score of the worst side was
used to calculate the total score [9,28].
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calculated the SRD% by dividing the SRD with the max-
imal total score of the Mini-BESTest (28 points). Similarly,
the SRD of each subcomponent was divided with its max-
imal total score (6 or 10 points). To analyze systematic
changes of the mean between testers and test sessions, we
used Bland-Altman plots [33].
Results
All participants completed both test sessions. None of
the participants changed their PD medication between
the test sessions, nor did they report that any forms of
adverse events or change of health status had occurred.
Inter-rater reproducibility
The participants’ mean total score of the Mini-BESTest
was found to be 20.2 points when assessed by rater A
and 21.3 points when assessed by rater B (Table 3).
Regarding inter-rater reproducibility, the Mini-BESTestTable 3 Inter-rater and test-retest reproducibility of the Mini-
Mean SD Range Mean SD Range
Inter-rater reproducibility Rater A Rater B
Mini-BESTest, total score 20.2 2.6 15-25 21.3 2.7 15-26
Anticipatory postural adjustments 3.6 1.2 1-6 4.1 1.0 2-6
Postural responses 4.2 1.0 3-6 3.7 1.1 1-6
Sensory orientation 5.7 0.6 4-6 5.9 0.5 4-6
Dynamic gait 6.7 1.4 5-10 7.7 1.1 5-9
Test-retest reproducibility Session 1 Session 2
Mini-BESTest, total score 20.2 2.6 15-25 20.5 2.9 14-26
Anticipatory postural adjustments 3.6 1.2 1-6 3.7 1.1 2-6
Postural responses 4.2 1.0 3-6 4.4 1.1 3-6
Sensory orientation 5.7 0.6 4-6 5.9 0.4 5-6
Dynamic gait 6.7 1.4 5-10 6.5 1.7 4-10
SD = Standard Deviation, ICC = Intra Class Correlation, CI = Confidence Interval, SEM
SRD = Smallest Real Difference (1.96 × √2 × SEM), SRD% = 1(SRD/maximal total scshowed good reliability (ICC = 0.72) and acceptable in-
ternal consistency (Cronbach’s alpha = 0.87). In addition,
our findings on agreement showed the SEM to be 1.5
points, whereas the SRD score revealed a measurement
error of 4.1 points (15% of the maximal total score). The
Bland and Altman graph (Figure 1A) illustrates the
occurrence of a systematic difference, showing that rater
B scored the participants higher than did rater A
(p = 0.003). However no heteroscedasticity was observed.
Our findings on the subcomponents of the Mini-
BESTest showed the measurement error to be highest
for the postural responses (38% of the maximal sub-
component score). Conversely, the measurement error
was lowest for sensory orientation (17% of the maximal
subcomponent score).
Test-retest reproducibility
The participants’ mean total score of the Mini-BESTest
was found to be 20.2 points for test session one and 20.5BESTest and its subcomponents
P-value ICC2.1 95% CI Cronbach’s
alpha
SEMagreement SRD SRD%
0.003 0.72 0.37-0.87 0.87 1.5 4.1 14.61
0.007 0.65 0.31-0.83 0.83 0.7 1.9 31.72
0.043 0.43 0.09-0.69 0.63 0.8 2.3 38.32
0.265 0.54 0.22-0.76 0.70 0.4 1.0 16.72
0.000 0.48 0.24-0.75 0.75 1.1 2.9 29.02
0.447 0.80 0.60-0.90 0.88 1.2 3.4 12.11
0.602 0.79 0.60-0.90 0.88 0.5 1.4 23.32
0.110 0.70 0.45-0.85 0.83 0.6 1.6 26.72
0.185 0.54 0.33-0.81 0.77 0.3 0.8 13.32
0.363 0.78 0.57-0.89 0.87 0.7 2.0 20.02
= Standard Error of Measurement (√within subjects error variance),
ore) × 100, 2(SRD/maximal subcomponent score) × 100.
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good reliability (ICC = 0.80) and acceptable internal
consistency (Cronbach’s alpha = 0.88). Our findings on
agreement showed a measurement error of 3.4 points
(12% of the maximal total score). The Bland-Altman
graph (Figure 1B) showed that, apart from one outlier,
no heteroscedasticity was observed. Regarding the agree-
ment of the Mini-BESTest’s subcomponents, we found
the measurement error to be highest for the postural
responses (27% of the maximal subcomponent score).
Conversely, the measurement error was lowest for sensory
orientation (13% of the maximal subcomponent score).
Discussion
This is the first study to use a methodology similar to
clinical practice to investigate the reproducibility of
the Mini-BESTest, as well as its subcomponents, in
PD. We found good reliability [31] (ICC > 0.70), as well
as acceptable internal consistency [30] (Cronbach’s
alpha = 0.87 and 0.88, respectively), for both inter-rater
and test-retest reproducibility. However, the agreement
was considered low [34] with the measurement error
accounting for, respectively, 15% (4.1 points) and 12%
(3.4 points) of the maximal total score.
Seemingly, the reliability of both inter-rater and test-
retest reproducibility in this study was good. Nevertheless,
these results may seem low compared to prior studies of
the Mini-BESTest, with inter-rater ICC scores ranging
from 0.91 to 0.99 [14,15,18,22] and where test-retest
scores have ranged from 0.88 to 0.97 [14,15,18,22]. How-
ever, it is difficult to compare directly our results on inter-
rater reproducibility with previous studies because either
our methodology (with two independent raters) or the
participants differs. Indeed, whereas our methodology is
comparable to the study of Tsang et al., [22] they investi-
gated individuals with chronic stroke. Considering theFigure 1 Bland & Altman graphs presenting the Mini-BESTest for inte
rater A and B is plotted against the mean of rater A and B. (B) The difference
sessions. The solid line represents the mean difference between the two testsprevalence of fluctuations of both motor [35] and non-
motor [36] symptoms in PD, this makes a direct compari-
son rather faulty. Leddy et al. [14] on the other hand,
studying exclusively elderly with PD, used only one person
to administrate the test, whereas three observers rated
the test performance. We consider this to be a method
that tests the reproducibility of the rating scale of the
Mini-BESTest, rather than its reproducibility from a
clinical perspective. Moreover, because ICC values are
influenced by variability [23], it is possible that the
reasonably low degree of variability in this study (including
only participants at Hoehn & Yahr stages 2 and 3, and
with the range of Mini-BESTest scores accounting for
approximately 40% of the total test score) affected the
ICC values negatively.
Hitherto, no previous studies have reported the inter-
rater or test-retest agreement of the Mini-BESTest in
PD. However, in individuals with mild-to-moderate
stroke, Tsang et al. [22] found the measurement error to
be 3 points (11% of the maximal total score) with a test-
retest design, which was similar to what we found.
Moreover, our results of test-retest agreement are also
comparable to those found by Steffen et al. [37] on the
Bergs balance scale in PD. Whereas they found the meas-
urement error to be 5 points out of 56 (9% of the maximal
test score), our results of 3.4 points out of 28 (12% of the
maximal test score) are just slightly higher. Seemingly,
the aforementioned studies (well-designed by appear-
ance and performed in different contexts), similar to
ours, have found the measurement error to account for
approximately 10% of the total score. Measurement
errors of that size, requiring changes of a magnitude
that is rare to achieve [38-40], are bound to make it
difficult for clinicians to rely on their results with confi-
dence (thereby limiting the instruments clinical value).
However, it might be relevant to highlight that theser-rater (A) and test-retest (B) reliability. (A) The difference between
between test session 1 and 2 is plotted against the mean of the two
and the dotted line two standard deviations (limits of agreement).
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rather strict formula containing 95% confidence [24,32]
(meaning that one can be 95% certain that the results
are correct). One might consider if it could be of higher
clinical value to calculate the measurement error with
80-90% confidence instead [41], something likely to
result in a more manageable measurement error that
can be relied upon with 80-90% certainty.
The analysis of the subcomponents of the Mini-BESTest
showed that sensory orientation (consisting of only
stationary exercises) had the highest agreement, both
regarding inter-rater and test-retest reproducibility.
Accordingly, the more dynamic subcomponent of postural
responses had the lowest agreement. These results were in
accordance with those found by Tsang et al. [22], where
items associated with postural responses showed the
lowest agreement. This is not surprising because the
reactive postural responses subcomponent includes
asking persons, possibly frightened of falling, to lean their
bodyweight into the hands of the test administrator, who
also needs to be consistent regarding how far to lean the
persons before suddenly releasing the support. Such a task
seems likely to be more challenging than simply to assess
the time a person is able to stand on a foam surface with
his or her eyes closed. One might argue that these kinds of
challenging, nevertheless important, items may be likely to
require skilled and well-trained raters.
At inter-rater reproducibility, a systematic bias occurred
between the raters, revealing the less experienced rater
to score the subjects higher (Figure 1). However, the
difference in results between raters (SRD = 4.1) was only
marginally larger than between a single rater at two
separate occasions (SRD = 3.4). This may indicate that
both administrators had a similar understanding of how
to administer the test, and that it is quite user-friendly
regardless of experience. On the other hand, it might
also have been due to the two training occasions that
had taken place prior to the data sampling, which in
case may emphasize the importance of the preparations
before using a test, whether for research purposes or
clinical practice. In addition, the results also indicate
that the Mini-BESTest consists of items that are diffi-
cult, yet important, to assess consistently in elderly with
mild-to-moderate PD. Nevertheless, our results suggest
that the Mini-BESTest is better suited to distinguish
between individuals, rather than to achieve high agree-
ment between test occasions in this population. Future
studies, preferably on a more heterogeneous sample,
need to investigate whether this may be due to the fluc-
tuations of symptoms in PD [35,36] (something that
might make this population difficult to assess reliably)
or whether measures can be taken to increase the agree-
ment of the Mini-BESTest (such as clearer instructions
and increments).Limitations
This study has several limitations. First of all, our partici-
pants can be considered as a convenience sample, repre-
senting only elderly with mild-to-moderate PD who were
interested in participating in a balance intervention, there-
fore our findings can be generalized only to this specific
population. In addition, because the total Mini-BESTest
scores in this study ranged from 15 to 25 points, we
have investigated only this particular interval of the
test. Although most training interventions in research
[25,42,43], as well as in the clinic, tend to address indi-
viduals at the mild-to-moderate stage of the disease,
clinical practice also includes treating individuals at
more advanced stages of the disease. Moreover, our
methodology of using raters with different experience
was (although relevant with regard to clinical practice)
rather strict- hence it is possible that the results would
have been different if both raters had had similar
experience. Furthermore, it is possible that the less-
experienced test administrator experienced a learning
effect during the course of data collection, a form of
bias that also might have occurred with the partici-
pants as well as with the experienced test administra-
tor at the test-retest assessments (that occurred 7 days
after the initial assessments). However, we found no
signs of this in our data.
Clinical relevance
The importance for clinicians to be aware of the agree-
ment of any clinical tool cannot be overestimated.
Given the subjective aspects of any test, which include
giving instructions and rating performance in general, it
is important to know to what extent the outcome may
depend upon a measurement error rather than on the
actual test performance. This is even more critical in
such a demanding task as evaluating an individual’s
balance performance, particularly when considering its
complex nature. Given the fall-prone nature of a popu-
lation such as those with PD, where balance problems
are all too frequent, this may be of particular value.
Some of the major challenges in obtaining reliable
results from many balance tests lie in giving the patients
clear and concise instructions while simultaneously
ensuring that they will not fall and, at the same time,
acknowledging their test performance with an adequate
rating. This study has added important information
regarding the reproducibility of the Mini-BESTest in
elderly with mild-to-moderate PD assessed with a meth-
odology assimilating clinical practice. As we investigated
the SRD, these results can be used to evaluate individual
treatment. Moreover, these results can also be applied to
a group level, (by dividing the SRD found here, with the
squared root of the number of participants investigated)
[32]. Furthermore, this study also highlighted which
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ficult to assess consistently, indicating what aspects of
the Mini-BESTest test might be beneficial to practice
extra carefully prior to balance assessments in those with
PD. Moreover, these results may also serve as an indica-
tor of which subcomponents may need to be refined
with regard to instructions to the patient as well as fur-
ther clarifications of how the rating ought to be per-
formed, in order to limit the subjective character of the
test to as large an extent as possible. With such mea-
sures, we believe that there is great potential to enhance
the clinical utility of such a promising test as the Mini-
BESTest.
Conclusions
The Mini-BESTest showed good inter-rater and test-retest
reproducibility regarding reliability. However, regarding
agreement, the measurement error was considered high,
with postural responses being the subcomponent with
the lowest agreement. This indicates that the Mini-
BESTest is able to distinguish between individuals with
mild to moderate PD; however, when used in clinical
balance assessments, the large measurement error needs
to be accounted for.
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